Communiqués Novo Integrated Sciences, Inc.

Actions

NVOS

US67011T3005

Installations et services en soins de santé

Marché Fermé - OTC Markets 17:05:42 01/10/2026			Varia. 5j.	Varia. 1 janv.
0,000600 ^USD	0,00%		-84,62%	-77,78%

06/05/25	Novo Integrated Sciences, Inc. annonce la démission de Michael Pope de son poste de membre du conseil d'administration, avec effet au 1er mai 2025.	CI
18/12/24	Novo Integrated Sciences, Inc. annonce ses résultats pour l'exercice clos le 31 août 2024	CI

Communiqués

18/12/24	Novo Integrated Sciences : Annual Report for Fiscal Year Ending August 31, 2024 (Form 10-K)	PU
18/12/24	Novo Integrated Sciences : Reports 2024 Fiscal Year Financial Results Form 8 K	PU
06/11/24	Novo Integrated Sciences : Failure to Satisfy Listing Rule Form 8 K	PU
23/10/24	Novo Integrated Sciences : Termination of Material Agreement Form 8 K	PU
19/07/24	Novo Integrated Sciences Reports Fiscal Year 2024 Third Quarter Financial Results	BU
18/07/24	Novo Integrated Sciences Receives Commencement of Disbursement Notice for SBLC Leasing and Monetizing Program	BU
13/06/24	Novo Integrated Sciences Receives Confirmation of Issuance of SBLC by HSBC for SBLC Leasing and Monetizing Program	BU
06/06/24	Novo Integrated Sciences’ Board of Directors Approves Increase of Maximum Amount Under Stock Repurchase Program to $10 Million	BU
05/06/24	Acenzia Selected to Participate in Protein Industries Canada Program to Develop Plant Based Protein Products	BU
03/06/24	Novo Integrated Sciences and RC Consulting Consortium Group Amend $70,000,000 Promissory Note	BU
31/05/24	Novo Integrated Sciences’ Board of Directors Conducting Strategic Review to Increase Maximum Amount under Stock Repurchase Program	BU
30/05/24	Novo Integrated Sciences Receives Confirmation of Ready, Willing and Able (RWA) Issued by HSBC for SBLC Leasing and Monetizing Program	BU
15/04/24	Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial Results	BU
11/04/24	Novo Integrated Sciences Closes on $6,210,000 Securities Purchase Agreement	BU
10/04/24	Novo Integrated Sciences : Private Placement - Form 8-K	PU
26/03/24	Novo Integrated Sciences Provides Update on Certain Current Actions and Events	BU
21/02/24	Novo Integrated Sciences Subsidiary, Clinical Consultants International, Signs Agreement with Futura Surgicare Pvt Ltd.	BU
20/02/24	Novo Integrated Sciences Receives Limited Waiver to Securities Purchase Agreement for $70,000,000 Promissory Note	BU
16/02/24	Novo Integrated Sciences Appoints New President	BU
22/01/24	Novo Integrated Sciences Reports Fiscal Year 2024 First Quarter Financial Results	BU
19/12/23	Blacksheep Trust Files Partial Assignment of $1 Billion Dollar Gold Backed Bond to Novo Integrated Sciences	BU
14/12/23	Novo Integrated Sciences Reports 2023 Fiscal Year Financial Results	BU
05/12/23	Novo Integrated Sciences Signs Master Collaboration Agreement with Psychocare Health Pvt. Ltd. India	BU
04/12/23	Novo Integrated Sciences’ Purchase and Sale Agreement to Acquire Ophir Collection Receives Court Approval	BU
24/11/23	Novo Integrated Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement	BU